Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight...

- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada.  -...

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic...

CNPC’s Well Shendi Take-1 reaches 10,910-meter milestone

BEIJING, Feb. 25, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn: jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE="...

Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

HONG KONG, Feb. 25, 2025 /PRNewswire/ -- On 21 February, Guo Guangchang, Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China...

“The Future of Travel”: Trip.com Group to Showcase Next-Gen Tech at ITB Berlin 2025

ATRenew to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform...

ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0% Full Year 2024 Gross Margin Compared to...
1...3,9563,9573,958...4,316Page 3,957 of 4,316